Author |
Topic: Fresh Research - PNP inhibitors (Read 284 times) |
|
floridian
Guest
|
This is basic bio but could be relevant. If so, it is probably years away, but worth thinking about. Also ties into the lymphatoid papulosis thread.
A new class of drugs is being developed for treating diseases involving the proliferation of T-cells, including T-cell leukemias, psoriasis, rheumatoid arthritis and Crohn's disease. http://www.eurekalert.org/pub_releases/2004-04/aps-ams041104.php
While not listed in that article, cluster headaches may also be respondent to PNP inhibitors. Cluster heads show pronounced activation of their T-cells.
The PNP enzyme is linked to purine and xanthine metabolism (caffeine is a xanthine).
If nothing else, this will give us one more tool to probe the workings of the beast.
|
|
 IP Logged |
|
|
|
|
|
|
Home
Help
Search
Members
Member Map
Login
Register
Reply
Notify of replies
Send Topic
Print
Quote
Modify
Remove
test rss